Difference between revisions of "20.109(F20):Journal club presentation"
From Course Wiki
Noreen Lyell (Talk | contribs) |
Noreen Lyell (Talk | contribs) |
||
Line 9: | Line 9: | ||
'''Malaria drug discovery''' | '''Malaria drug discovery''' | ||
+ | |||
+ | #Istvan ''et. al.'' "[[Media:Istvan Plasmodium Niemann-Pick type C1.pdf|''Plasmodium'' Niemann-Pick type C1-related protein is a druggable target reguired for parasite membrane homeostasis.]]" (2019) eLife. 8:e40529. | ||
+ | |||
Brill, E. et al. “Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer.” (2017) Oncotarget. PMID:29158830 | Brill, E. et al. “Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer.” (2017) Oncotarget. PMID:29158830 |
Revision as of 23:56, 24 July 2020
FIND ARTICLES FOR CATEGORIES: MALARIA BIOLOGY, SMM STUDIES, DRUG DISCOVERY RESEARCH
P. falciparum biology
Malaria drug discovery
- Istvan et. al. "Plasmodium Niemann-Pick type C1-related protein is a druggable target reguired for parasite membrane homeostasis." (2019) eLife. 8:e40529.